Tevosol Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Investors
-
2
Tevosol General Information
Description
Manufacturer of portable warm perfusion devices intended for better recovery of organs, resuscitation of dysfunctional organs, and longer preservation of function with the opportunity for ex vivo treatment and evaluation. The company's system consists of a common hardware platform with organ-specific single-use disposable cassettes for lungs, hearts, livers, and kidneys that can be used to preserve, assess, and reclaim donor organs for lifesaving transplants, thereby helping medical professionals and surgeons recover, resuscitate, transport, evaluate, and transplant more donor organs.
Contact Information
Website
www.tevosol.comCorporate Office
- 10937 120 Street
- Edmonton, Alberta T5H 3R3
- Canada
Corporate Office
- 10937 120 Street
- Edmonton, Alberta T5H 3R3
- Canada
Tevosol Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 09-Feb-2021 | Completed | Generating Revenue | |||
| 5. Seed Round | 15-Aug-2019 | Completed | Startup | |||
| 4. Accelerator/Incubator | 05-Aug-2019 | Completed | Startup | |||
| 3. Angel (individual) | 29-Jun-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2016 | $25K | $25K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Tevosol Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tevosol Patents
Tevosol Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019095079-A1 | Apparatus for perfusion of an excised organ | Inactive | 20-Nov-2017 | ||
| US-20200329699-A1 | Apparatus and method for ex vivo lung ventilation with a varying exterior pressure | Active | 14-Dec-2016 | ||
| EP-3209128-A1 | Novel composition and solution with controlled calcium ion level, and related method and use for reperfusion | Inactive | 24-Oct-2014 | ||
| EP-3209128-A4 | Novel composition and solution with controlled calcium ion level, and related method and use for reperfusion | Inactive | 24-Oct-2014 | ||
| EP-3128836-A1 | Modulation of calcium ion homeostasis in harvested transplantable hearts | Active | 10-Apr-2014 | A01N1/126 |
Tevosol Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tevosol Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TEC Edmonton | Accelerator/Incubator | |||
| Texas Medical Center | Venture Capital | Minority |
Tevosol FAQs
-
When was Tevosol founded?
Tevosol was founded in 2015.
-
Where is Tevosol headquartered?
Tevosol is headquartered in Edmonton, Canada.
-
What is the size of Tevosol?
Tevosol has 7 total employees.
-
What industry is Tevosol in?
Tevosol’s primary industry is Diagnostic Equipment.
-
Is Tevosol a private or public company?
Tevosol is a Private company.
-
What is Tevosol’s current revenue?
The current revenue for Tevosol is .
-
How much funding has Tevosol raised over time?
Tevosol has raised $3.54M.
-
Who are Tevosol’s investors?
TEC Edmonton and Texas Medical Center have invested in Tevosol.
-
When was Tevosol acquired?
Tevosol was acquired on 09-Feb-2021.
-
Who acquired Tevosol?
Tevosol was acquired by Bridge to Life.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
